Tower Bridge Advisors reduced its stake in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 3.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 70,619 shares of the company’s stock after selling 2,336 shares during the period. Tower Bridge Advisors’ holdings in Roche were worth $2,489,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of RHHBY. Brooklyn Investment Group acquired a new position in shares of Roche during the third quarter worth about $40,000. IHT Wealth Management LLC acquired a new position in Roche during the 3rd quarter worth approximately $236,000. Verity Asset Management Inc. bought a new position in shares of Roche during the 3rd quarter worth approximately $253,000. Canopy Partners LLC raised its holdings in shares of Roche by 4.6% in the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after purchasing an additional 344 shares during the last quarter. Finally, Confluence Investment Management LLC lifted its position in shares of Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after purchasing an additional 2,910 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the stock. UBS Group raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Morgan Stanley assumed coverage on Roche in a report on Wednesday, February 12th. They issued an “equal weight” rating for the company. Finally, Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Roche presently has an average rating of “Hold”.
Roche Trading Up 0.7 %
Shares of RHHBY stock opened at $41.74 on Friday. The company has a fifty day moving average price of $38.24 and a two-hundred day moving average price of $38.43. Roche Holding AG has a one year low of $29.20 and a one year high of $42.43. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86.
About Roche
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
- Five stocks we like better than Roche
- What Are Some of the Best Large-Cap Stocks to Buy?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to start investing in penny stocks
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.